Profil
Kate E.
Broderick is Senior Vice President-Research & Development at TriLink BioTechnologies LLC since 2022.
Formerly, Dr. Broderick was Senior Vice President-Research & Development at Inovio Pharmaceuticals, Inc. from 2019 to 2022.
Dr. Broderick was Chief Innovation Officer at Maravai Lifesciences Holdings, Inc. from 2022 to 2025.
Dr. Broderick earned a doctorate from the University of Glasgow.
Aktiva positioner av Kate Broderick
| Företag | Position | Start |
|---|---|---|
TriLink BioTechnologies LLC
TriLink BioTechnologies LLC Miscellaneous Commercial ServicesCommercial Services Engages in oligonucleotides, modified nucleoside triphosphates, mRNA and long RNA | Teknisk/Vetenskaplig/F&U Direktör | 2022-01-01 |
Tidigare kända positioner av Kate Broderick
| Företag | Position | Slut |
|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-09-01 |
| INOVIO PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-07-01 |
Kate Brodericks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
TriLink BioTechnologies LLC
TriLink BioTechnologies LLC Miscellaneous Commercial ServicesCommercial Services Engages in oligonucleotides, modified nucleoside triphosphates, mRNA and long RNA | Commercial Services |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Maravai Lifesciences Holdings, Inc.
Maravai Lifesciences Holdings, Inc. BiotechnologyHealth Technology Develops and sells drug therapies, diagnostics and novel vaccines | Health Technology |
















